These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26153762)

  • 21. Specific celiac disease antibodies in children on a gluten-free diet.
    Hogen Esch CE; Wolters VM; Gerritsen SA; Putter H; von Blomberg BM; van Hoogstraten IM; Houwen RH; van der Lely N; Mearin ML
    Pediatrics; 2011 Sep; 128(3):547-52. PubMed ID: 21859913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
    Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I
    Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective activation of naïve B cells with unique epitope specificity shapes autoantibody formation in celiac disease.
    Das S; Stamnaes J; Høydahl LS; Skagen C; Lundin KEA; Jahnsen J; Sollid LM; Iversen R
    J Autoimmun; 2024 Jun; 146():103241. PubMed ID: 38754235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.
    Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I
    Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet.
    Not T; Ziberna F; Vatta S; Quaglia S; Martelossi S; Villanacci V; Marzari R; Florian F; Vecchiet M; Sulic AM; Ferrara F; Bradbury A; Sblattero D; Ventura A
    Gut; 2011 Nov; 60(11):1487-93. PubMed ID: 21471568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of circulating autoreactive pre-plasma cells fueled by naive B cells in celiac disease.
    Lindeman I; Høydahl LS; Christophersen A; Risnes LF; Jahnsen J; Lundin KEA; Sollid LM; Iversen R
    Cell Rep; 2024 Apr; 43(4):114045. PubMed ID: 38578826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of IgM deficiency following a gluten-free diet in seronegative celiac disease.
    Montenegro L; Piscitelli D; Giorgio F; Covelli C; Fiore MG; Losurdo G; Iannone A; Ierardi E; Di Leo A; Principi M
    World J Gastroenterol; 2014 Dec; 20(46):17686-9. PubMed ID: 25516687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease.
    Dotsenko V; Tewes B; Hils M; Pasternack R; Isola J; Taavela J; Popp A; Sarin J; Huhtala H; Hiltunen P; Zimmermann T; Mohrbacher R; Greinwald R; Lundin KEA; Schuppan D; Mäki M; Viiri K;
    Nat Immunol; 2024 Jul; 25(7):1218-1230. PubMed ID: 38914866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease.
    Sblattero D; Florian F; Azzoni E; Ziberna F; Tommasini A; Not T; Ventura A; Bradbury A; Marzari R
    J Autoimmun; 2004 Feb; 22(1):65-72. PubMed ID: 14709414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells.
    Paolella G; Caputo I; Marabotti A; Lepretti M; Salzano AM; Scaloni A; Vitale M; Zambrano N; Sblattero D; Esposito C
    PLoS One; 2013; 8(12):e84403. PubMed ID: 24391952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease.
    Martucciello S; Sposito S; Esposito C; Paolella G; Caputo I
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longevity, clonal relationship, and transcriptional program of celiac disease-specific plasma cells.
    Lindeman I; Zhou C; Eggesbø LM; Miao Z; Polak J; Lundin KEA; Jahnsen J; Qiao SW; Iversen R; Sollid LM
    J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33095260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Injection of prototypic celiac anti-transglutaminase 2 antibodies in mice does not cause enteropathy.
    Lindstad CB; du Pré MF; Stamnaes J; Sollid LM
    PLoS One; 2022; 17(4):e0266543. PubMed ID: 35385534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.
    Husby S; Murray JA; Katzka DA
    Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A human autoimmune organoid model reveals IL-7 function in coeliac disease.
    Santos AJM; van Unen V; Lin Z; Chirieleison SM; Ha N; Batish A; Chan JE; Cedano J; Zhang ET; Mu Q; Guh-Siesel A; Tomaske M; Colburg D; Varma S; Choi SS; Christophersen A; Baghdasaryan A; Yost KE; Karlsson K; Ha A; Li J; Dai H; Sellers ZM; Chang HY; Dunn JCY; Zhang BM; Mellins ED; Sollid LM; Fernandez-Becker NQ; Davis MM; Kuo CJ
    Nature; 2024 Aug; 632(8024):401-410. PubMed ID: 39048815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy.
    Tosco A; Maglio M; Paparo F; Rapacciuolo L; Sannino A; Miele E; Barone MV; Auricchio R; Troncone R
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):293-8. PubMed ID: 18728524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal anti-transglutaminase 2 immunoglobulin A deposits in children at risk for coeliac disease (CD): data from the PreventCD study.
    Borrelli M; Maglio M; Korponay-Szabó IR; Vass V; Mearin ML; Meijer C; Niv-Drori H; Ribes-Koninckx C; Roca M; Shamir R; Troncone R; Auricchio R
    Clin Exp Immunol; 2018 Mar; 191(3):311-317. PubMed ID: 29114847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease.
    Tosco A; Aitoro R; Auricchio R; Ponticelli D; Miele E; Paparo F; Greco L; Troncone R; Maglio M
    Clin Exp Immunol; 2013 Jan; 171(1):69-75. PubMed ID: 23199325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2.
    du Pré MF; Blazevski J; Dewan AE; Stamnaes J; Kanduri C; Sandve GK; Johannesen MK; Lindstad CB; Hnida K; Fugger L; Melino G; Qiao SW; Sollid LM
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31727780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of transglutaminase 2 in human gut epithelial cells: Implications for coeliac disease.
    Amundsen SF; Stamnaes J; Lundin KEA; Sollid LM
    PLoS One; 2023; 18(6):e0287662. PubMed ID: 37368893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.